1. Home
  2. BOTJ vs MAIA Comparison

BOTJ vs MAIA Comparison

Compare BOTJ & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank of the James Financial Group Inc.

BOTJ

Bank of the James Financial Group Inc.

HOLD

Current Price

$17.78

Market Cap

71.6M

Sector

Finance

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.19

Market Cap

44.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOTJ
MAIA
Founded
1998
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.6M
44.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BOTJ
MAIA
Price
$17.78
$1.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.8K
446.4K
Earning Date
10-30-2025
11-07-2025
Dividend Yield
2.26%
N/A
EPS Growth
N/A
N/A
EPS
1.74
N/A
Revenue
$47,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.18
N/A
Revenue Growth
8.53
N/A
52 Week Low
$11.56
$0.87
52 Week High
$18.50
$2.74

Technical Indicators

Market Signals
Indicator
BOTJ
MAIA
Relative Strength Index (RSI) 60.36 52.13
Support Level $17.50 $1.07
Resistance Level $18.04 $1.25
Average True Range (ATR) 0.61 0.12
MACD -0.01 0.04
Stochastic Oscillator 63.84 51.68

Price Performance

Historical Comparison
BOTJ
MAIA

About BOTJ Bank of the James Financial Group Inc.

Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: